Intrexon Corp. (NYSE:XON) Given Average Rating of “Buy” by Analysts
Shares of Intrexon Corp. (NYSE:XON) have been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the firm. Three analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $43.78.
Several research analysts recently commented on XON shares. Zacks Investment Research raised shares of Intrexon Corp. from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a research note on Tuesday, July 19th. JMP Securities reaffirmed a “buy” rating on shares of Intrexon Corp. in a research note on Sunday, July 17th. Wunderlich reaffirmed a “buy” rating and issued a $50.00 target price on shares of Intrexon Corp. in a research note on Thursday, July 7th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $57.00 target price on shares of Intrexon Corp. in a research note on Wednesday, June 29th. Finally, Vetr raised shares of Intrexon Corp. from a “strong sell” rating to a “buy” rating and set a $27.01 target price on the stock in a research note on Thursday, July 28th.
In related news, SVP Nir Nimrodi purchased 4,000 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The shares were acquired at an average price of $26.12 per share, for a total transaction of $104,480.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 55.10% of the stock is currently owned by corporate insiders.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/10/intrexon-corp-nysexon-given-average-rating-of-buy-by-analysts.html
A number of hedge funds have recently added to or reduced their stakes in the stock. Iridian Asset Management LLC CT boosted its stake in Intrexon Corp. by 5.4% in the second quarter. Iridian Asset Management LLC CT now owns 4,061,478 shares of the company’s stock valued at $99,953,000 after buying an additional 206,763 shares during the period. Vanguard Group Inc. boosted its stake in shares of Intrexon Corp. by 2.8% in the second quarter. Vanguard Group Inc. now owns 3,768,107 shares of the company’s stock worth $92,732,000 after buying an additional 101,083 shares during the period. State Street Corp boosted its stake in shares of Intrexon Corp. by 60.4% in the second quarter. State Street Corp now owns 2,501,773 shares of the company’s stock worth $61,567,000 after buying an additional 941,882 shares during the period. AQR Capital Management LLC boosted its stake in shares of Intrexon Corp. by 208.1% in the second quarter. AQR Capital Management LLC now owns 1,391,208 shares of the company’s stock worth $34,237,000 after buying an additional 939,597 shares during the period. Finally, BlackRock Institutional Trust Company N.A. boosted its stake in shares of Intrexon Corp. by 7.9% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,289,979 shares of the company’s stock worth $31,746,000 after buying an additional 94,354 shares during the period. Institutional investors and hedge funds own 84.05% of the company’s stock.
Intrexon Corp. (NYSE:XON) traded up 2.12% during midday trading on Monday, hitting $30.32. 1,018,534 shares of the stock were exchanged. The stock’s market cap is $3.59 billion. Intrexon Corp. has a 1-year low of $18.52 and a 1-year high of $43.76. The company’s 50 day moving average is $27.34 and its 200-day moving average is $28.08.
Intrexon Corp. (NYSE:XON) last posted its quarterly earnings results on Tuesday, August 9th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.16. The business had revenue of $52.50 million for the quarter, compared to analysts’ expectations of $53.78 million. Intrexon Corp. had a negative return on equity of 19.00% and a negative net margin of 96.65%. The company’s revenue was up 17.0% compared to the same quarter last year. During the same period last year, the business posted ($0.37) earnings per share. On average, analysts expect that Intrexon Corp. will post ($1.36) earnings per share for the current year.
Intrexon Corp. Company Profile
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.
Receive News & Ratings for Intrexon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp. and related companies with MarketBeat.com's FREE daily email newsletter.